Icahn School of Medicine at Mount Sinai, Department of Medicine, Division of General Internal Medicine, Brickner Research Unit: Community Medicine and TB/UV Studies, New York City, USA.
Mr. Vincent applies germicidal ultraviolet (GUV) cleansing technology and tools to control the transmission of tuberculosis and in high-risk settings. He was the project manager and UV lighting specialist for the Tuberculosis Ultraviolet Shelter Study (TUSS), (1997-2004). TUSS—a multidisciplinary, multicenter epidemiological field trial of ultraviolet air cleansing effectiveness formed by St. Vincent’s Hospital and the Harvard School of Public Health (HSPH) advanced UVGI application for airborne disease control in homeless shelters. At the Icahn School of Medicine, Mount Sinai, he is working on reducing the rate of hospital-acquired infections (HAIs), by benchmarking the efficacy of various technologies including: mobile, whole-room UVC devices for decontamination of surfaces from pathogens such as MRSA, and C. Difficile. Since 2008 he has been on faculty at the Harvard Course: Building Design and Engineering to Prevent Airborne Infection – An International Approach. He has taught a shortened course in Pretoria, South Africa and Mumbai and New Delhi, India. He has provided technical assistance on GUV projects in India, Myanmar and Pakistan. Since 2016, Mr. Vincent serves at the Coordinator for the StopTB Partnership working Group: End TB Transmission Initiative (ETTI). He provided expert input on GUV for the WHO Guidelines on tuberculosis infection prevention and control, 2019 update. Mr. Vincent is the chair of the ASHRAE GCP 37 developing guidelines for the application of upper-room ultraviolet germicidal irradiation systems (UVGI/GUV). He chairs the CIE TC 6-52 to test upper room GUV fixtures.